Talk to our Consultant - Impotence Agents Market Trends, Key Players, Demand, Opportunities, & Forecast By 2028

Global Impotence Agents Market Research Report: Forecast (2023-2028)

By Indication (Erectile Dysfunction, Others), By Product (Tablets Avanafil (Stendra), Sildenafil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra), Injections, Urethral Suppository, Others), By Distr... ... y, Others), By Distribution Channel (Hospitals, Pharmacies, Online, Retail), By Company (Pfizer Inc., Mylan N.V., Novartis AG, Hikma Pharmaceuticals Plc, Aurobindo Pharma, Abbvie Inc., Melinta Therapeutics, LLC, Bristol-Myers Squibb Company, GSK Plc, Bayer AG). Read more

Healthcare
Aug 2023
Pages 189
Report Format: PDF, Excel, PPT

Market Definition

Impotence agents, also known as ED (Erectile Dysfunction) drugs or PDE-5 (phosphodiesterase type 5) inhibitors, are medications that help men achieve & maintain a penile erection sufficient for sexual activity. These agents work by blocking PDE5 and preventing the breakdown of cGMP (cyclic guanosine monophosphate), which relaxes smooth muscles in the penis’s arteries and allows a rush of blood to flow into the penis, thereby creating an erection firm enough for sexual intercourse. The most common impotence agents prescribed by healthcare professionals include Sildenafil (Viagra), Tadalafil (Cialis), Vardenafil (Levitra), & Avanafil (Stendra).

Market Insights & Analysis: Global Impotence Agents Market (2023-28)

The Global Impotence Agents Market is projected to grow at a CAGR of around 6.8% during the forecast period, i.e., 2023-28. The market is poised for significant growth owing to the globally rising prevalence of ED (Erectile Dysfunction) owing to the increased burden of lifestyle diseases, such as atherosclerosis, hypertension, diabetes, obesity, depression, & stress, among other medical conditions, resulting in a growing demand for impotence agents.

Report Coverage	Details
Study Period	Historical Data: 2018-21
	Base Year: 2022
	Forecast Period: 2023-28
CAGR (2023-2028)	6.8%
Regions Covered	North America: USA, Canada, Mexico
	Europe: France, Germany, Italy, United Kingdom, Spain, Qatar, Rest of Europe
	Asia-Pacific: China, India, Japan, Australia, South Korea, Rest of Asia-Pacific
	South America: Brazil, Argentina, Rest of South America
	Middle East & Africa: UAE, Saudi Arabia, Egypt, South Africa, Rest of Middle East & Africa
Key Companies Profiled	Pfizer Inc., Mylan N.V., Novartis AG, Hikma Pharmaceuticals Plc, Aurobindo Pharma, Abbvie Inc., Melinta Therapeutics, LLC, Bristol-Myers Squibb Company, GSK Plc, Bayer AG.
Unit Denominations	USD Million/Billion

The advent of the COVID-19 pandemic played a crucial role in augmenting the incidence of these health conditions due to sedentary lifestyles and increased stress levels among people. In addition, the rising geriatric population and the rapidly increasing alcohol & tobacco consumption are other prominent aspects amplifying the demand for ED drugs and, in turn, boding well for the impotence agents market.

Moreover, the steady growth in the number of ED devices also presents growth opportunities for the market, backed by the non-invasive nature as well as zero adverse effects of shock wave therapy. Healthcare device manufacturers are putting active emphasis on developing innovative technologies like magnetic therapy for ED management, creating new avenues for market growth. Additionally, increased investments in healthcare research on finding effective treatments are also projected to drive the global impotence agents market through 2028.

Introduction
1. Product Definition
2. Research Process
3. Assumptions
Market Segmentation
Executive Summary
Global Impotence Agents Market Regulations, Norms, & Product Standards
Global Impotence Agents Market Trends & Developments
Global Impotence Agents Market Dynamics
1. Drivers
2. Challenges
Global Impotence Agents Market Imports, Exports Statistics
Global Impotence Agents Market Hotspots & Opportunities
Global Impotence Agents Market Value Chain & Stakeholder Margin Analysis
Global Impotence Agents Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Indication
    1. Erectile Dysfunction
    2. Others
  2. By Product
    1. Tablets
      1. Avanafil (Stendra)
      2. Sildenafil (Viagra)
      3. Tadalafil (Cialis)
      4. Vardenafil (Levitra)
    2. Injections
    3. Urethral Suppository
    4. Others
  3. By Distribution Channel
    1. Hospitals
    2. Pharmacies
      1. Online
      2. Retail
  4. By Company
    1. Revenue Shares
    2. Competition Characteristics
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
North America Impotence Agents Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Indication- Market Size & Forecast 2018-2028F, USD Million
  2. By Product- Market Size & Forecast 2018-2028F, USD Million
  3. By End User- Market Size & Forecast 2018-2028F, USD Million
  4. By Distribution Channel- Market Size & Forecast 2018-2028F, USD Million
  5. By Company- Market Size & Forecast 2018-2028F, USD Million
  6. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
4. Canada Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
5. Mexico Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
South America Impotence Agents Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Indication- Market Size & Forecast 2018-2028F, USD Million
  2. By Product- Market Size & Forecast 2018-2028F, USD Million
  3. By End User- Market Size & Forecast 2018-2028F, USD Million
  4. By Distribution Channel- Market Size & Forecast 2018-2028F, USD Million
  5. By Company- Market Size & Forecast 2018-2028F, USD Million
  6. By Country
    1. Brazil
    2. Argentina
    3. Rest of South America
3. Brazil Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
4. Argentina Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
Europe Impotence Agents Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Indication- Market Size & Forecast 2018-2028F, USD Million
  2. By Product- Market Size & Forecast 2018-2028F, USD Million
  3. By End User- Market Size & Forecast 2018-2028F, USD Million
  4. By Distribution Channel- Market Size & Forecast 2018-2028F, USD Million
  5. By Company- Market Size & Forecast 2018-2028F, USD Million
  6. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
4. France Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
5. The UK Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
6. Spain Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
7. Italy Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
The Middle East & Africa Impotence Agents Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Indication- Market Size & Forecast 2018-2028F, USD Million
  2. By Product- Market Size & Forecast 2018-2028F, USD Million
  3. By End User- Market Size & Forecast 2018-2028F, USD Million
  4. By Distribution Channel- Market Size & Forecast 2018-2028F, USD Million
  5. By Company- Market Size & Forecast 2018-2028F, USD Million
  6. By Country
    1. The UAE
    2. Saudi Arabia
    3. Qatar
    4. Egypt
    5. South Africa
    6. Rest of the Middle East & Africa
3. The UAE Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
4. Saudi Arabia Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
5. Qatar Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
6. Egypt Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
7. South Africa Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
Asia-Pacific Impotence Agents Market Analysis (2018-2028F)
1. Market Size & Analysis
  1. Market Revenues (USD Million)
2. Market Share & Analysis
  1. By Indication- Market Size & Forecast 2018-2028F, USD Million
  2. By Product- Market Size & Forecast 2018-2028F, USD Million
  3. By End User- Market Size & Forecast 2018-2028F, USD Million
  4. By Distribution Channel- Market Size & Forecast 2018-2028F, USD Million
  5. By Company- Market Size & Forecast 2018-2028F, USD Million
  6. By Country
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Australia
    6. Rest of Asia-Pacific
3. China Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
4. India Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
5. Japan Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
6. South Korea Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
7. Australia Impotence Agents Market Analysis (2018-2028F)
  1. By Product- Market Size & Forecast 2018-2028F, USD Million
  2. By End User- Market Size & Forecast 2018-2028F, USD Million
Competitive Benchmarking & Company Profiles
1. Competition Matrix
  1. Product Portfolio
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances
  6. Strategic Initiatives
2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc.)
  1. Pfizer Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Mylan N.V.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Novartis AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Hikma Pharmaceuticals Plc
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Aurobindo Pharma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Abbvie Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Melinta Therapeutics, LLC
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Bristol-Myers Squibb Company
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. GSK Plc
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Bayer AG
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
About Us & Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying